VainutisKVaitkeviciusMD

PubMed

• 33 citations
  Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer
  Edgar Ben-Josef, Anthony F. Shields, Ulka N. Vaishampayan, Vainutis K. Vaitkevicius, Basil F. El-Rayes, P McDermott, Jay Burmeister, T. Bossenberger, Philip A. Philip> ;International Journal of Radiation Oncology Biology Physics. 2004 Jun 1
• 5 citations
  Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
  Sana Al-Sukhun, Mark M. Zalupski, Edgar Ben-Josef, Vainutis K. Vaitkevicius, Philip A. Philip, Renate L. Soulen, Donald W. Weaver, Volkan Adsay, Lance K. Heilbrun, Ken...> ;American Journal of Clinical Oncology. 2003 Dec 1
• 26 citations
  Developments in the systemic therapy of pancreatic cancer
  Basil F. El-Rayes, Anthony F. Shields, Vainutis K. Vaitkevicius, Philip A. Philip> ;Cancer Investigation. 2003 May 3
• 21 citations
  Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians.
  Nat L. Pernick, Fazlul H. Sarkar, Philip A. Philip, Patricia Arlauskas, Anthony F. Shields, Vainutis K. Vaitkevicius, Michael C. Dugan, N. Volkan Adsay> ;Pancreas. 2003 Jan 1
• 4 citations
  A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies.
  Ulka N. Vaishampayan, Edgar Ben-Josef, Philip A. Philip, Vainutis K. Vaitkevicius, Wei Du, Kenneth J. Levin, Anthony F. Shields> ;International Journal of Radiation Oncology Biology Physics. 2002 Jul 1
• Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
  Alexey L. Glazyrin, Sreenivasa R. Chinni, Samir Alhasan, Volkan Adsay, Vainutis K. Vaitkevicius, Fazlul H. Sarkar> ;International Journal of Oncology. 2002 Jan 1
• Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model.
  Ramzi M. Mohammad, N. Volkan Adsay, Philip A. Philip, George R. Pettit, Vainutis K. Vaitkevicius, Fazlul H. Sarkar> ;Anti-Cancer Drugs. 2001 Oct 1
• 99 citations
  Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.
  Philip A. Philip, Mark M. Zalupski, Vainutis K. Vaitkevicius, Patricia Arlauskas, Ruth Chaplen, Lance K. Heilbrun, Volkan Adsay, Donald W. Weaver, Anthony F. Shields> ;Cancer. 2001 Aug 1
• CD95-related apoptotic machinery is functional in pancreatic cancer cells.
  Alexey L. Glazyrin, Volkan Adsay, Vainutis K. Vaitkevicius, Fazlul H. Sarkar> ;Pancreas. 2001 May 1
• 5 citations
  Cost analysis of pancreatic carcinoma treatment.
  Wei Du, Daniel R. Touchette, Vainutis K. Vaitkevicius, William P. Peters, Anthony F. Shields> ;Cancer. 2000 Nov 1
• Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
  Shabbir Ahmed, Vainutis K. Vaitkevicius, Mark M. Zalupski, Wei Du, Patricia Arlauskas, Craig Gordon, Christopher M. Kellogg, Anthony F. Shields> ;American Journal of Clinical Oncology. 2000 Aug 1
• Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer.
  He, Z., Evelhoch, J. L., Mohammad, R. M., Adsay, N. V., Pettit, G. R., Vaitkevicius, V. K., Sarkar, F. H.> ;Pancreas. 2000 Jul 6
• 2 citations
  Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
  Ramzi M. Mohammad, Yiwei Li, Anwar N. Mohamed, George R. Pettit, Volkan Adsay, Vainutis K. Vaitkevicius, Ayad Al-Katib, Fazlul H. Sarkar> ;Pancreas. 1999 Nov 1
• Molecular effects of taxol and caffeine on pancreatic cancer cells.
  Gururajanna, B., Al-Katib, A., Li, Y. W., Aranha, O., Vaitkevicius, V. K., Sarkar, F. H.> ;International journal of molecular medicine. 1999 Oct 27
• Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.
  N V Adsay, Sanaa T. Dergham, Fred Koppitch, Michael C. Dugan, Anwar N. Mohamed, Vainutis K. Vaitkevicius, Fazlul H. Sarkar> ;Pancreas. 1999 Mar 1
• Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinoma.
  Yiwei Li, Mahbubur Bhuiyan, Vainutis K. Vaitkevicius, Fazlul H. Sarkar> ;Pancreas. 1999 Jan 1
• 9 citations
  Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy.
  Sanaa T. Dergham, Michael C. Dugan, Fazlul H. Sarkar, Vainutis K. Vaitkevicius> ;Journal of Hepato-biliary-pancreatic Surgery. 1998 Nov 1
• An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies.
  Ramzi M. Mohammad, Ayad Al-Katib, George R. Pettit, Vainutis K. Vaitkevicius, Urwashi S. Joshi, Volkan Adsay, Adhip P.N. Majumdar, Fazlul H. Sarkar> ;Clinical Cancer Research. 1998 Apr 1
• Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus.
  Urwashi S. Joshi, Sanaa T. Dergham, Yong Q. Chen, Michael C. Dugan, John D. Crissman, Vainutis K. Vaitkevicius, Fazlul H. Sarkar> ;Pancreas. 1998 Mar 1
• Molecular analysis of the p53 gene in pancreatic adenocarcinoma.
  Yiwei Li, Mahbubur Bhuiyan, Vainutis K. Vaitkevicius, Fazlul H. Sarkar> ;Diagnostic Molecular Pathology. 1998 Feb 1
• Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma
  Mark M. Zalupski, Anthony F. Shields, Philip A. Philip, Michael J. Kraut, Patricia LoRusso, Lance K. Heilbrun, Vainutis K. Vaitkevicius> ;Investigational New Drugs. 1998 Jan 1
• Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.
  Ramzi M. Mohammad, Michael C. Dugan, Anwar N. Mohamed, Victor P. Almatchy, Thomas M. Flake, Sanaa T. Dergham, Anthony F. Shields, Ayad A. Al-Katib, Vainutis K. Vaitkev...> ;Pancreas. 1998 Jan 1
• 44 citations
  The clinical significance of p21WAF1/CIP‐1 and p53 expression in pancreatic adenocarcinoma
  T B S Sanaa Dergham, Michael C. Dugan, Urwashi S. Joshi, Yong C. Chen, Wei Du, Daryn W. Smith, B A Patricia Arlauskas, John D. Crissman, Vainutis K. Vaitkevicius, Fazl...> ;Cancer. 1997 Aug 1
• 44 citations
  Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
  Sanaa T. Dergham, Michael C. Dugan, Patricia Arlauskas, Wei Du, Vainutis K. Vaitkevicius, John D. Crissman, Fazlul H. Sarkar> ;International Journal of Pancreatology. 1997 Jun 1
• Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer.
  Shridhar, V., Rivard, S., Wang, X., Shridhar, R., Paisley, C., Mullins, C., Beirnat, L., Dugan, M., Sarkar, F., Miller, O. J., Vaitkevicius, V. K., Smith, D. I.> ;Oncogene. 1997 May 8
• Join now to see all